As noted in a prior blog entry, GlaxoSmithKline had been sued by NY for failing to publish negative results from its Paxil clinical trials. Today, GSK settled that suit for $2.5 million to NY, and promised to publish the results of all studies conducted after Dec. 27, 2000 and related studies. However, they have 16 months to get all of these online.
I'm waiting to see whether the new publication of the clinical trial results by some in BigPharma will pressure others in BigPharma and SmallPharma to publish their trials ... or will NIH latch onto this as a good thing and get regulations passed to make it industry standard?
Comments